Table 4: 10 recurrent stroke cases with NOACs and 7 recurrent stroke cases with VKA.
NOACs: Non-vitamin K Antagonist Oral Anticoagulants,VKA: vitamin K antagonists, warfarin, mRS: Modified Rankin Scale, DA: Dabigatran, RI: Rivaroxaban, AP: Apixaban, Re: recurrent, 1st: First Event Type of stroke: CE: Cardioembolic Stroke, AT: Atherothrombotic Brain Infarction, TIA: Transient Ischemic Attack, CH: Cerebral Hemorrhage*p<0.05
Case Age Initial amount of NOACs Type of stroke Swithched NOACs Stroke volume(cm3) Discharge mRS Micrbleeds on MRI hemorrhagic infarction
NOACs group(n=10) 1 67 DA 300mg CERe DA 300mg 0.48 1 none none
2 71 DA 220mg ATRe DA 300mg 0.32 0 none none
3 67 RI 15mg CE1st DA 300mg 1.16 2 none none
4 86 RI 10mg CERe RI 10mg 15.95 1 none none
5 74 RI 10mg CE1st DA 220mg 0.05 3 none none
6 89 RI 10mg ATRe API 5mg 0.07 0 none none
7 72 RI 15mg CERe API 10mg 1.27 2 none none
8 80 API 5mg TIA API 5mg 0 0 none none
9 92 DA 220mg CERe API 5mg 7.69 4 none none
10 78 DA 220mg CERe RI 10mg 6.71 4 positive positive
mean 78.6(9.1) 3.37(5.25)* 1.7(1.5)*
VKA group(n=7) 1 82 CERe RI 10mg 24.84 5 none none
2 71 CERe DA 300mg 1.22 0 none none
3 82 CERe RI 10mg 62.65 4 none none
4 81 CERe RI 10mg 12.77 5 none none
5 90 CERe API 5mg 59.09 4 none none
6 83 CERe RI 15mg 3.28 4 positive positive
7 88 CERe API 5mg 28.07 4 none none
mean 82.4(6.1) 27.42(24.95)* 3.7(1.7)*